Biosite's Triage BNP assay
This article was originally published in The Gray Sheet
Executive Summary
Premarket approval application for congestive heart failure test will be reviewed by FDA's Clinical Chemistry and Clinical Toxicology Devices Panel on March 24. The blood-based Triage B-type natriuretic peptide (BNP) is intended to provide in 20 minutes results that will serve as an aid in diagnosing CHF, the firm maintains